2015 annual financial data
XTL Biopharmaceuticals 2015 Operating cash flow margin
Direct answer
Operating cash flow margin was 31,016.67%.
Operating income was -3,611,000 USD and net income was -4,311,000 USD.
Operating cash flow was -1,861,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -6,000 USD
- Operating income
- -3,611,000 USD
- Net income
- -4,311,000 USD
- Operating cash flow
- -1,861,000 USD